HOME >> BIOLOGY >> NEWS
Hope available for patients with anemia and myelodysplastic syndrome

(San Diego, Calif., December 8, 2003) Several studies presented during the 45th Annual Meeting of the American Society of Hematology (ASH) provide hope for patients with red blood cell diseases in the form of potential new treatments, as well as guidance for health care providers in caring for patients.

Anemia is a disease in which the blood lacks adequate healthy red blood cells to carry appropriate levels of oxygen to patients' tissues, making them feel tired. Many types of anemia exist, each with its own cause, such as an iron or vitamin deficiency, blood loss, chronic illness, a genetic or acquired defect or disease, or a medication side effect. Anemia can be temporary or long-term and can range from mild to severe. Anemia affects more than three million Americans, making it the most common blood disorder in the United States. Women and people with chronic diseases are at increased risk for the condition.

A related disease is myelodysplastic syndrome, a disease that in mild cases may present primarily as anemia. Myelodysplastic syndrome (MDS) is characterized by abnormal blood-forming cells of the bone marrow, which produce too few red blood cells, white blood cells, and platelets. The bone marrow is unable to produce blood cells effectively, and many of the formed cells are abnormal or defective. The abnormal cells are usually destroyed before they leave the bone marrow or shortly after they enter the bloodstream. As a result, patients experience a shortage of blood cells, which is reflected in their low blood counts. MDS may be a form of cancer, according to most hematologists, since it is considered a clonal disease with a single population of abnormal cells.

"These blood disorders are not simply quality of life diseases, but carry with them serious health concerns that may endanger patients' lives," said Stanley Schrier, M.D., President-Elect of the American Society of Hem
'"/>

Contact: Aimee Frank
amf@spectrumscience.com
202-955-6222
American Society of Hematology
8-Dec-2003


Page: 1 2 3 4 5 6

Related biology news :

1. National Corn Growers Association announces valuable maize genome data now available to scientists
2. New human embryonic stem-cell lines to be made available to researchers
3. Should publicly funded research be free and available to the public?
4. Laser technology to map industrial plant gases available through Alberta Research Council
5. Why results from genetic tests should be available to medical insurance companies
6. Research grants available for faculty at minority serving institutions
7. Physician experts available to speak on California fires and smoke inhalation
8. Seven CD-ROM global GIS data set available from AGI
9. QuikClot (TM) will be made available to public
10. 2 Million of yeast to triple available drug treatments
11. K-State professor studies medications available for llamas, alpacas

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2019)... ... 17, 2019 , ... The possibility that ethnic differences exist ... for many years. These observed differences may be manifest in alterations in safety, ... residing in different geographic regions. This created the perceived necessity to fully and ...
(Date:1/14/2019)... ... January 14, 2019 , ... Join the live ... hear about key topics in data quality, including:, ,     State ... engagement ,     Smartphone and wearable based performance measures ,     Data quality ...
(Date:1/10/2019)... ... 2019 , ... A major goal for pharmaceutical companies has ... significantly more expensive in vivo studies in order to reduce costs and improve ... researchers have begun to adopt 3D cell culture models which have been shown ...
Breaking Biology News(10 mins):
(Date:1/30/2019)... ... 30, 2019 , ... The Society for Laboratory Automation and ... best practices for laboratory automation and screening. This year the conference will be ... Visikol will be at booth #345 and throughout the conference will highlight its ...
(Date:1/28/2019)... ... January 28, 2019 , ... Fragment-based ... weight compounds. In this early stage, false positives can be problematic due to ... is vital that screening techniques are highly sensitive to detect weak interactions. ...
(Date:1/24/2019)... , ... January 22, 2019 , ... ... each trial has its own set of assumptions, and RFP creation and management ... evaluating bids is like comparing apples to oranges. These challenges can ultimately lead ...
(Date:1/20/2019)... ... January 16, 2019 , ... On January 15 of this year, ... by Asymmetrex director James L. Sherley, M.D., Ph.D. The PGCB was ... the PGCB and CellTrials.org. Now in its 21st year of operation, the PGCB ...
Breaking Biology Technology:
Cached News: